Effects on the hemostatic system and liver function in relation to Implanon® and Norplant® -: A prospective randomized clinical trial

被引:45
作者
Egberg, N
van Beek, A
Gunnervik, C
Hulkko, S
Hirvonen, E
Larsson-Cohn, U
Bennink, HC
机构
[1] NV Organon, Sci Dev Grp, Med Res Project, NL-5430 BH Oss, Netherlands
[2] Karolinska Sjukhuset, Dept Clin Chem & Blood Coagulat, Stockholm, Sweden
[3] Varnamo Sjukhuset, Varnamo, Sweden
[4] Laakarikeskus Hemi Oy, Lahti, Finland
[5] Kalevankadun Laakariasema, Helsinki, Finland
[6] Univ Sjukhuset, Linkoping, Sweden
关键词
contraceptive implant; etonogestrel/3-ketodesogestrel; levonorgestrel; hemostasis; liver function; Norplant((R)); Implanon((R));
D O I
10.1016/S0010-7824(98)00070-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In this prospective randomized clinical trial, two long-term contraceptive implants were studied with respect to hemostasis and liver function in 86 healthy young women. The two implants used were Implanon(R), containing the progestagen etonogestrel (the biologically active metabolite of desogestrel) and Norplant(R), the implant containing the progestagen levonorgestrel. The results of the trial showed that both implants had similar small effects on the hemostatic system that are not suggestive of a tendency towards thrombosis. The effect on liver function was characterized by increases in total bilirubin and gamma-glutamyl transferase and decreases in alanine aminotransferase and aspartate aminotransferase. (C) 1998 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 26 条
  • [1] NEW SENSITIVE AND HIGHLY SPECIFIC CHROMOGENIC PEPTIDE SUBSTRATE FOR FACTOR-XA
    AURELL, L
    FRIBERGER, P
    KARLSSON, G
    CLAESON, G
    [J]. THROMBOSIS RESEARCH, 1977, 11 (05) : 595 - 609
  • [2] DETERMINATION OF VITAMIN-K SENSITIVE COAGULATION-FACTORS IN PLASMA - STUDIES ON 3 METHODS USING SYNTHETIC CHROMOGENIC SUBSTRATES
    BERGSTROM, K
    EGBERG, N
    [J]. THROMBOSIS RESEARCH, 1978, 12 (03) : 531 - 547
  • [3] MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C
    BERTINA, RM
    KOELEMAN, BPC
    KOSTER, T
    ROSENDAAL, FR
    DIRVEN, RJ
    DERONDE, H
    VANDERVELDEN, PA
    REITSMA, PH
    [J]. NATURE, 1994, 369 (6475) : 64 - 67
  • [4] BOTTIGER LE, 1980, LANCET, V1, P1097
  • [5] FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C
    DAHLBACK, B
    CARLSSON, M
    SVENSSON, PJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) : 1004 - 1008
  • [6] FARLEY TMM, 1995, LANCET, V346, P1582
  • [7] HEMOSTASIS PROFILE IN SMOKING AND NONSMOKING WOMEN TAKING LOW-DOSE ORAL-CONTRACEPTIVES
    FRUZZETTI, F
    RICCI, C
    FIORETTI, P
    [J]. CONTRACEPTION, 1994, 49 (06) : 579 - 592
  • [8] ORAL-CONTRACEPTIVE ESTROGEN DOSE AND THE RISK OF DEEP VENOUS THROMBOEMBOLIC DISEASE
    GERSTMAN, BB
    PIPER, JM
    TOMITA, DK
    FERGUSON, WJ
    STADEL, BV
    LUNDIN, FE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (01) : 32 - 37
  • [9] *IPPF MED ADV PAN, 1995, IPPF MED B, V29, P1
  • [10] JESPERSEN J, 1988, DAN MED BULL, V35, P1